Financhill
Back

Denali Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
18

DNLI
Denali Therapeutics

Last Price:
$20.88
Seasonality Move:
-14.4%
Sell
30

CATX
Perspective Therapeutics

Last Price:
$3.32
Seasonality Move:
36.42%
Sell
18
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $20.38. The Score for DNLI is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $20.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 30.62 Sell
Chaikin Money Flow: -66741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.33 - 24.73) Sell
Bollinger Bands (100): (23.02 - 28.68) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.94 Sell
Relative Strength Index (14 RSI): 29.96 Sell
Chaikin Money Flow: 455171 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 3.96) Sell
Bollinger Bands (100): (5.8 - 14.84) Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.9 Sell
20-day SMA: 22.53 Sell
50-day SMA: 25.08 Sell
200-day SMA: 23.05 Sell
8-day EMA: 21.02 Sell
20-day EMA: 22.34 Sell
50-day EMA: 24.16 Sell
200-day EMA: 23.91 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.1 Buy
20-day SMA: 3.37 Sell
50-day SMA: 6.84 Sell
200-day SMA: 11.96 Sell
8-day EMA: 3.18 Buy
20-day EMA: 3.74 Sell
50-day EMA: 6.16 Sell
200-day EMA: 9.62 Sell

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $1.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):